News & Blog

Tag Archives: FDA

National Brain Tumor Society’s 2015 Legislative Agenda

To guide our public policy advocacy efforts each year, National Brain Tumor Society creates an annual “Legislative Agenda.” Our yearly Legislative Agenda reflects the larger strategy and goals of the Organization, and our activities in carrying out the agenda directly influences our ability to deliver on our mission of better treatments, and ultimately a cure, […]

Encouraging Results from Novocure Clinical Trial

Novocure, a company that creates medical devices to treat cancer, announced this weekend that their Novo-TTF-100A system (now being called Optune), in combination with temozolomide (also know as Temodar or TMZ), demonstrated improved survival in newly diagnosed glioblastoma multiforme (GBM) patients in a clinical trial, compared with temozolomide alone. The announcement was made at the […]

Can this treatment help me live a longer and better life?

Why was I asked to sit on a panel with two top officials from the U.S. Food and Drug Administration (FDA), two leading neuro-oncologists, an associate professor of neuropsychiatry, and an executive from the biopharmaceutical company, Genentech? Because, as a five-year brain tumor survivor and volunteer advocate with the National Brain Tumor Society, I want […]

Share